Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Melissa Pong, MS

Executive Director of Quality Assurance



Melissa Pong, MS, is a Quality and Compliance leader with over 20 years in biopharmaceutical industry with extensive quality, compliance, and operational experience. She currently serves as the Executive Director of Quality Assurance at PICI. She is responsible for leading the GXP quality assurance activities to ensure PICI has an effective Quality Management System and is compliant with regulatory requirements.

Prior to joining PICI, Pong was the Executive Director for Clinical QA at Nektar Therapeutics and at Acerta Pharma, a member of the AstraZeneca Group. At Acert Pharma, she established the Clinical QA infrastructure and played a key role in achieving FDA approval of acalabrutinib. Prior to Acerta Pharma, she held a variety of roles as head of QA for a GXP service provider, contract auditor, GCP consultant, clinical trial manager, and site monitor.